Bavarian Nordic Tests Mpox Vaccine in 2- to 11-Year-Olds, Critics Question Safety and Need
Critics told The Defender the trials are flawed because they compare the vaccine’s safety in kids to its safety in adults rather than to a placebo. They also cited serious side effects, including myocarditis, associated with the vaccine.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed